Vanessa Mitsialis,Sarah Wall,Peng Liu,Jose Ordovas-Montanes,Tamar Parmet,Marko Vukovic,Dennis Spencer,Michael Field,Collin McCourt,Jessica Toothaker,Athos Bousvaros,Boston Children’s Hospital Inflammatory Bowel Disease Center,Sonia Ballal,Silvana Bonilla,Rima Fawaz,Laurie N. Fishman,Alejandro Flores,Victor Fox,Amit S. Grover,Leslie Higuchi,Susanna Huh,Stacy Kahn,Christine Lee,Munir Mobassaleh,Jodie Ouahed,Randi G. Pleskow,Brian Regan,Paul A. Rufo,Sabina Sabharwal,Jared Silverstein,Menno Verhave,Anne Wolf,Lori Zimmerman,Naamah Zitomersky,Brigham and Women’s Hospital Crohn’s and Colitis Center,Jessica R. Allegretti,Punyanganie De Silva,Sonia Friedman,Matthew Hamilton,Joshua Korzenik,Frederick Makrauer,Beth-Ann Norton,Rachel W. Winter,Alex K. Shalek,Leslie Kean,Bruce Horwitz,Jeffrey Goldsmith,George Tseng,Scott B. Snapper,Liza Konnikova

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background & Aims</h3><p>Studies are needed to determine the mechanisms of mucosal dysregulation in patients with inflammatory bowel diseases (IBD) and differences in inflammatory responses of patients with ulcerative colitis (UC) vs Crohn's disease (CD). We used mass cytometry (CyTOF) to characterize and compare immune cell populations in the mucosa and blood from patients with IBD and without IBD (controls) at single-cell resolution.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We performed CyTOF analysis of colonic mucosa samples (n=87) and peripheral blood mononuclear cells (PBMCs, n=85) from patients with active or inactive UC or CD and controls. We also performed single-cell RNA-sequencing, flow cytometry, and RNA in situ hybridization analyses to validate key findings. We used random forest modeling to identify differences in signatures across subject groups.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Compared with controls, colonic mucosa samples from patients with IBD had increased abundances of HLA-DR+CD38+ T cells, including T-regulatory cells that produce inflammatory cytokines; CXCR3+ plasmablasts; and IL1B+ macrophages and monocytes. Colonic mucosa samples from patients with UC were characterized by expansion of IL17A+ CD161+ effector memory T cells and IL17A+ T-regulatory cells; expansion of HLA-DR+CD56+ granulocytes; and reductions in type 3 innate lymphoid cells. Mucosal samples from patients with active CD were characterized by IL1B+HLA-DR+CD38+ T cells, IL1B+TNF+IFNG+ naïve B cells, IL1B+ dendritic cells (DCs), and IL1B+ plasmacytoid DCs. PBMCs from patients with active CD differed from those of active UC in that the PBMCs from patients with CD had increased IL1B+ T-regulatory cells, IL1B+ DCs and IL1B+ plasmacytoid DCs, IL1B+ monocytes, and fewer group 1 innate lymphoid cells. Random forest modeling differentiated active UC from active CD in colonic mucosa and blood samples; top discriminating features included many of the cellular populations identified above.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>We used single-cell technologies to identify immune cell populations specific to mucosa and blood samples from patients with active or inactive CD and UC and controls. This information might be used to develop therapies that target specific cell populations in patients with different types of IBD.</p>

What problem does this paper attempt to address?

The paper attempts to address the problem of identifying specific immune cell characteristics of ulcerative colitis (UC) and Crohn's disease (CD), two types of inflammatory bowel disease (IBD), in mucosal and peripheral blood. Specifically, the study aims to detail the differences in immune cell composition and function between these two diseases using single-cell analysis techniques (such as CyTOF and single-cell RNA sequencing), thereby providing a basis for developing therapeutic strategies targeting specific cell populations. ### Main Research Questions: 1. **Identify specific immune cell characteristics of UC and CD**: Using single-cell analysis techniques, identify the differences in immune cell characteristics in the colonic mucosa and peripheral blood of UC and CD patients compared to healthy controls. 2. **Understand the differences in immune cell composition and function between UC and CD**: Explore the differences in immune cell types, memory states, cytokine expression, etc., between UC and CD, especially during active and inactive phases. 3. **Develop diagnostic and therapeutic strategies based on immune cell characteristics**: Use machine learning methods to construct models that can distinguish between UC and CD, providing support for precise diagnosis and personalized treatment of the diseases. ### Research Background: - **Pathological mechanisms of IBD**: IBD is a chronic inflammatory disease of the intestine, including UC and CD. UC mainly affects the colon, while CD can occur throughout the digestive tract. The pathogenesis of IBD is complex, involving interactions between genetics, environment, microbiota, and the immune system. - **Limitations of existing treatments**: Although some biologics can induce and maintain remission, many patients respond poorly or lose response to these treatments, necessitating new therapeutic strategies. - **Application of single-cell analysis techniques**: Traditional immunological studies are often limited to specific cell populations and signaling pathways, while single-cell analysis techniques (such as CyTOF and scRNA-seq) can provide a more comprehensive cellular landscape, helping to identify new therapeutic targets. ### Research Methods: - **Sample collection**: Collect colonic mucosa and peripheral blood samples from UC, CD patients, and healthy controls. - **Single-cell analysis**: Use CyTOF for multiparameter analysis of cell surface markers and cytokines, and use scRNA-seq for transcriptome analysis. - **Validation experiments**: Validate key findings through flow cytometry and RNA in situ hybridization. - **Machine learning modeling**: Use random forest models to identify characteristic differences between different disease groups and construct classification models. ### Main Findings: - **Specific immune cell characteristics of UC and CD**: Increased IL-17A+ CD161+ effector memory T cells and IL-17A+ Treg cells in the mucosa of UC patients, while increased IL-1β+ HLA-DR+ CD38+ T cells, IL-1β+ TNF+ IFNγ+ naive B cells, IL-1β+ dendritic cells, and IL-1β+ plasmacytoid dendritic cells in the mucosa of CD patients. - **Differences in peripheral blood**: Increased IL-1β+ Treg cells, IL-1β+ dendritic cells, and IL-1β+ plasmacytoid dendritic cells in the peripheral blood of CD patients, while decreased IL-1β+ Mφ/monocytes in the peripheral blood of UC patients. - **Machine learning model**: The constructed random forest model can accurately distinguish between UC and CD patients, especially in mucosal and peripheral blood samples. ### Conclusion: Through single-cell analysis techniques, researchers successfully identified specific immune cell characteristics of UC and CD in mucosal and peripheral blood, which may provide important clues for developing therapeutic strategies targeting specific cell populations. Additionally, the establishment of machine learning models provides new tools for the precise diagnosis and personalized treatment of IBD.

Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn’s Disease